Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optical coherence tomography assessment of incidence, morphological characteristics, and spontaneous healing course of edge dissections following percutaneous coronary intervention with stent implantation in patients with non-ST segment elevation myocardial infarction.
Antonsen L, Thayssen P, Hansen HS, Junker A, Veien KT, Hansen KN, Hougaard M, Jensen LO. Antonsen L, et al. Among authors: hansen kn, hansen hs. Int J Cardiol. 2016 Nov 15;223:466-474. doi: 10.1016/j.ijcard.2016.08.245. Epub 2016 Aug 14. Int J Cardiol. 2016. PMID: 27544607 Clinical Trial.
Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial.
Maeng M, Jensen LO, Galloe AM, Thayssen P, Christiansen EH, Hansen KN, Helqvist S, Botker HE, Lassen JF, Thuesen L. Maeng M, et al. Among authors: hansen kn. Am J Cardiol. 2009 Feb 1;103(3):345-9. doi: 10.1016/j.amjcard.2008.09.084. Epub 2008 Nov 12. Am J Cardiol. 2009. PMID: 19166687 Clinical Trial.
Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L. Jensen LO, et al. Among authors: hansen kn. Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578. Circ Cardiovasc Interv. 2008. PMID: 20031676
Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease.
Jensen LO, Thayssen P, Tilsted HH, Ravkilde J, Junker A, Hansen HS, Hansen KN, Pedersen KE, Sørensen HT, Thuesen L, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome SORT OUT IV investigators. Jensen LO, et al. Among authors: hansen kn, hansen hs. Cardiology. 2010;116(2):73-8. doi: 10.1159/000315136. Epub 2010 Jun 3. Cardiology. 2010. PMID: 20523042 Clinical Trial.
Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Jensen LO, Maeng M, Thayssen P, Tilsted HH, Terkelsen CJ, Kaltoft A, Lassen JF, Hansen KN, Ravkilde J, Christiansen EH, Madsen M, Sørensen HT, Thuesen L. Jensen LO, et al. Among authors: hansen kn. Am J Cardiol. 2012 Mar 1;109(5):629-35. doi: 10.1016/j.amjcard.2011.10.018. Epub 2011 Dec 5. Am J Cardiol. 2012. PMID: 22152969
2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial.
Jensen LO, Thayssen P, Christiansen EH, Tilsted HH, Maeng M, Hansen KN, Kaltoft A, Hansen HS, Bøtker HE, Krusell LR, Ravkilde J, Madsen M, Thuesen L, Lassen JF; SORT OUT IV Investigators. Jensen LO, et al. Among authors: hansen kn, hansen hs. J Am Coll Cardiol. 2012 Sep 25;60(13):1140-7. doi: 10.1016/j.jacc.2012.07.004. Epub 2012 Sep 5. J Am Coll Cardiol. 2012. PMID: 22958957 Free article. Clinical Trial.
Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).
Jensen LO, Thayssen P, Junker A, Maeng M, Tilsted HH, Kaltoft A, Hansen KN, Christiansen EH, Kristensen SD, Ravkilde J, Madsen M, Sørensen HT, Thuesen L, Lassen JF. Jensen LO, et al. Among authors: hansen kn. Am J Cardiol. 2012 Dec 1;110(11):1585-91. doi: 10.1016/j.amjcard.2012.07.022. Epub 2012 Sep 4. Am J Cardiol. 2012. PMID: 22959714 Clinical Trial.
Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial.
Egede R, Jensen LO, Hansen HS, Hansen KN, Junker A, Thayssen P. Egede R, et al. Among authors: hansen kn, hansen hs. EuroIntervention. 2013 Feb 22;8(10):1182-9. doi: 10.4244/EIJV8I10A182. EuroIntervention. 2013. PMID: 22987572 Free article. Clinical Trial.
Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Antonsen L, Maeng M, Thayssen P, Christiansen EH, Hansen KN, Kaltoft A, Hansen HS, Thuesen L, Lassen JF, Jensen LO. Antonsen L, et al. Among authors: hansen kn, hansen hs. Catheter Cardiovasc Interv. 2014 May 1;83(6):864-72. doi: 10.1002/ccd.25180. Epub 2013 Sep 30. Catheter Cardiovasc Interv. 2014. PMID: 23996918 Clinical Trial.
108 results